#Canada #Vancouver #Gluten-Free #Eshbal #Howard Group

Eshbal Engages The Howard Group to Bolster Investor Relations

Eshbal Functional Food Inc. (TSXV: ESBL), a prominent player in the development of gluten-free, health-oriented food products, recently announced its collaboration with The Howard Group Inc. This strategic engagement is set to enhance Eshbal’s investor relations and capital markets communication efforts. The announcement, made on September 16, 2025, marks a significant step forward for Eshbal as it aims to further solidify its market presence and continue its upward trajectory in the booming health food sector.

CEO Tomer Bar Meir emphasized the importance of this partnership, stating, “Having reached record revenue milestones, and nearing operationalization of our expanded North American platform, we look forward to expanding awareness of our story together with the Howard Group.” Eshbal’s decision to engage The Howard Group signifies its commitment to robust investor communication and strategic outreach as it prepares for further growth.

The Howard Group's Role

The Howard Group will undertake a comprehensive approach to investor relations, which includes targeted social media outreach, online awareness initiatives, and a series of both online and in-person interactive events. Grant Howard, President of The Howard Group, highlighted Eshbal’s successful track record, mentioning the company’s long history of creating quality gluten-free products. He noted a clear market opportunity within this multi-billion-dollar segment, recognizing the increasing demand for gluten-free options.

Financial Details

As part of the engagement agreement, Eshbal will retain The Howard Group for an initial six-month term, compensating them at a rate of $9,000 per month. Additionally, The Howard Group will be granted 250,000 options at an exercise price of $0.25, valid for three years from the grant date. These options will vest in four equal tranches every three months, with the first vesting occurring after three months following the grant.

Importantly, The Howard Group maintains a conflict-free relationship, as neither the organization nor its directors or shareholders hold any direct or indirect stake in Eshbal or its securities. This arm’s-length agreement ensures ethical standards and alignment with Eshbal's strategic goals.

Eshbal's Commitments and Future Goals

Eshbal Functional Food Inc. aims to leverage The Howard Group’s expertise to enhance awareness of its innovative gluten-free products, which cater specifically to individuals adhering to gluten-free diets—whether for health reasons or lifestyle choices. The company is keen to scale its operations across North America, focusing on organic growth while entering the 'better-for-you' food market.

Founded in 2025, Eshbal is rooted in food innovation, utilizing proprietary research and development processes to create a diverse range of food and nutraceutical products. This includes gluten-free, vegan, low-carb, sugar-free options, as well as dietary supplements that meet the growing consumer demand for healthier alternatives in food.

With the support of The Howard Group, Eshbal intends to communicate its vision and product offerings more effectively to prospective investors, strengthening its position in the market. As consumer preferences continue to shift toward health-conscious choices, Eshbal is positioned to capitalize on this trend, promising an expanding array of tasty, health-focused food products.

In conclusion, this partnership not only embodies Eshbal's proactive approach to investor relations but also showcases its unwavering commitment to becoming a leader in the gluten-free industry. Long-term, Eshbal aims to build upon its past successes while navigating the challenges and opportunities of a rapidly evolving market. To stay updated on their progress, visit Eshbal’s website.